Skip to main content

Resveratrol clinical trials: What’s the evidence?

If you are interested in anti-aging, or just the science behind healthy wine drinking, you must have seen the ads for resveratrol supplements. “All the benefits of wine without the alcohol” they might say, implying that the science is in and the matter decided. There is an impressive dossier of resveratrol research, now totaling some 3,000 research papers, and the beneficial effects of this wine-derived molecule are myriad. There is good reason why I dubbed resveratrol the “miracle molecule” in my book Age Gets Better with Wine.
In the book I also introduced what I call the “skeptic’s checklist,” a useful tool for evaluating claims about medical interventions and miracle supplements. The reason this is important is that while data from laboratory studies can reveal interesting properties and lines of research, what happens in a test tube is meaningless unless the effect can be documented in a clinical trial in humans. In order to obtain FDA clearance, for example, clinical trials need to document both safety and objectively measured effectiveness. But since herbal supplements do not fall under the FDA’s purview, there is wide leeway for frequently misleading often outrageous and claims. So without evidence from clinical trials (not the same thing as "clinically tested"), there is no way of knowing whether the product is doing any good or if it is in fact harmful.
There are a few clinical trials underway for resveratrol, and a very small number of published reports. Of the 12 papers that I found on a Medline search using “clinical trial” and “resveratrol,” 3 were not actual clinical trials but studies on blood or tissue in a lab. Another 3 used a wine extract with resveratrol along with the whole family of wine polyphenols, and the rest were what are called pharmacokinetics studies. These types of studies evaluate what is called “bioavailability” or the absorption and distribution of resveratrol after oral ingestion. Without exception they all found low but variable levels, even at high doses.
So it doesn’t appear that resveratrol alone explains the benefits of drinking wine. Synthetic derivatives, up to a thousand times more potent, are being developed so it may turn out that resveratrol opened the door to a new and powerful anti-aging products even if it isn’t the answer alone. For now, a skeptical approach seems the way to go.

Comments

Popular posts from this blog

Versatile resveratrol: the ultimate skin care ingredient?

  Part 1 Recently I was honored to join Professors David Sinclair of Harvard and Joseph Vercauteren of the University of Montpelleir at an anti-aging symposium at the invitation of Mathilde Thomas of Caudalie in Paris. Caudalie has been using wine extracts (and specifically resveratrol) in their products for more than 15 years, after Vercauteren identified it in wine grape vines. Sinclair has become well known for his work identifying the role of sirtuin (SIRT) genes in anti-aging, and resveratrol as a natural sirtuin activator. While much remains to be proven, it is fair to say that science is finally beginning to have an impact on skin care. With an increasing understanding of what causes aging in skin cells and how botanical antioxidants such as resveratrol work at a molecular level, there is no excuse to use anti-aging skin care products that don’t multitask. Before delving into the potential benefits of resveratrol in skin care, it may help to review ho...

Revisiting resveratrol: new findings rekindle anti-aging debate

Just when we thought the bloom was off the rosé for resveratrol, the anti-oxidant polyphenol from red wine with multiple anti-aging properties, along comes new research giving life to the debate. But first a bit of background: As I detailed in my book Age Gets Better with Wine , it is well-documented that wine drinkers live longer and have lower rates of many diseases of aging. Much or the credit for this has been given to resveratrol, though there isn’t nearly enough of it in wine to explain the effects. Nevertheless, I dubbed it the “miracle molecule” and when it was reported to activate a unique life-extension phenomenon via a genetic trigger called SIRT, an industry was born, led by Sirtris Pharmaceuticals, quickly acquired by pharma giant Glaxo. The hope was that resveratrol science could lead to compounds enabling people to live up to 150 years and with a good quality of life. But alas, researchers from other labs could not duplicate the results, and clinical studies disa...